You are here
Coronavirus (COVID-19): Information on medicines and medical devices
The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.
Please read the information below before contacting the TGA to see if your question is already answered.
Filters
Topics and product types
Audience
- Remove Advertisers filter Advertisers (18)
- Remove Consumers filter Consumers (32)
- Health professionals (36) Apply Health professionals filter
- Manufacturers (28) Apply Manufacturers filter
- Remove Sponsors filter Sponsors (32)
Filters applied:
- (-) Remove Consumers filter Consumers
- (-) Remove Advertisers filter Advertisers
- (-) Remove Sponsors filter Sponsors
19 May 2022
At the time of approving a vaccine, the TGA publishes extensive information about the product for both health professionals and the public.
17 May 2022
COVID-19 vaccines undergoing evaluation for provisional registration by the TGA
16 May 2022
COVID-19 vaccine batch release information is now available.
2 May 2022
The TGA has provisionally approved a booster dose of the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for individuals 18 years and older.
28 April 2022
The TGA has granted a number of provisional determinations in relation to COVID-19 vaccines.
5 April 2022
The Therapeutic Goods Administration (TGA) granted provisional approval to Janssen-Cilag Pty Ltd (known as Johnson & Johnson overseas) for its COVID-19 vaccine Janssen, making it the third COVID-19 vaccine to receive regulatory approval in Australia.
5 April 2022
The TGA has provisionally approved the Moderna COVID-19 vaccine, SPIKEVAX, for use in individuals aged 6 years and older.
5 April 2022
The TGA has granted provisional approval to AstraZeneca Pty Ltd for its COVID-19 vaccine
8 February 2022
Find information on complying with the rules around advertising and importing COVID-19 vaccines
8 November 2021
Updated guidance clarifying the interaction between TGA and AHPRA advertising guidelines.
Pages
Further information
Contact TGA Info
Tel: 1800 020 653
Email: info@tga.gov.au
Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.
Department of Health
Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.
Follow us
